SPIRIVA in Ususal Care

NCT00274079 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

395

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: SPIRIVA

Sponsor

Boehringer Ingelheim